BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36960072)

  • 21. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.
    Urdinez L; Erra L; Palma AM; Mercogliano MF; Fernandez JB; Prieto E; Goris V; Bernasconi A; Sanz M; Villa M; Bouso C; Caputi L; Quesada B; Solis D; Aguirre Bruzzo A; Katsicas MM; Galluzzo L; Weyersberg C; Bocian M; Bujan MM; Oleastro M; Almejun MB; Danielian S
    Front Immunol; 2022; 13():1020927. PubMed ID: 36405754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.
    Snow AL; Xiao W; Stinson JR; Lu W; Chaigne-Delalande B; Zheng L; Pittaluga S; Matthews HF; Schmitz R; Jhavar S; Kuchen S; Kardava L; Wang W; Lamborn IT; Jing H; Raffeld M; Moir S; Fleisher TA; Staudt LM; Su HC; Lenardo MJ
    J Exp Med; 2012 Nov; 209(12):2247-61. PubMed ID: 23129749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CARD11 regulates the thymic Treg development in an NF-κB-independent manner.
    Hu Y; Han L; Xu W; Li T; Zhao Q; Lu W; Sun J; Wang Y
    Front Immunol; 2024; 15():1364957. PubMed ID: 38650932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India.
    Gupta M; Aluri J; Desai M; Lokeshwar M; Taur P; Lenardo M; Bergerson J; Dalvi A; Mhatre S; Kulkarni M; Kambli P; Madkaikar M
    Front Immunol; 2018; 9():1049. PubMed ID: 29963038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
    Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
    Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CARD11 signaling in regulatory T cell development and function.
    Carter NM; Pomerantz JL
    Adv Biol Regul; 2022 May; 84():100890. PubMed ID: 35255409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.
    Dorjbal B; Stinson JR; Ma CA; Weinreich MA; Miraghazadeh B; Hartberger JM; Frey-Jakobs S; Weidinger S; Moebus L; Franke A; Schäffer AA; Bulashevska A; Fuchs S; Ehl S; Limaye S; Arkwright PD; Briggs TA; Langley C; Bethune C; Whyte AF; Alachkar H; Nejentsev S; DiMaggio T; Nelson CG; Stone KD; Nason M; Brittain EH; Oler AJ; Veltri DP; Leahy TR; Conlon N; Poli MC; Borzutzky A; Cohen JI; Davis J; Lambert MP; Romberg N; Sullivan KE; Paris K; Freeman AF; Lucas L; Chandrakasan S; Savic S; Hambleton S; Patel SY; Jordan MB; Theos A; Lebensburger J; Atkinson TP; Torgerson TR; Chinn IK; Milner JD; Grimbacher B; Cook MC; Snow AL
    J Allergy Clin Immunol; 2019 Apr; 143(4):1482-1495. PubMed ID: 30170123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.
    Shields AM; Bauman BM; Hargreaves CE; Pollard AJ; Snow AL; Patel SY
    J Clin Immunol; 2020 Feb; 40(2):406-411. PubMed ID: 31897776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus therapy restores the PD-1+ICOS+Tfh:CD45RA-Foxp3
    Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Liu G; Luo J
    Mol Immunol; 2022 Jul; 147():90-100. PubMed ID: 35523039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced IL-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis.
    Niu Q; Huang ZC; Wu XJ; Jin YX; An YF; Li YM; Xu H; Yang B; Wang LL
    Arthritis Res Ther; 2018 Aug; 20(1):200. PubMed ID: 30157931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production.
    Jeelall YS; Wang JQ; Law HD; Domaschenz H; Fung HK; Kallies A; Nutt SL; Goodnow CC; Horikawa K
    J Exp Med; 2012 Oct; 209(11):1907-17. PubMed ID: 23027925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular Helper CD4
    Zhang X; Ge R; Chen H; Ahiafor M; Liu B; Chen J; Fan X
    Mediators Inflamm; 2021; 2021():2058964. PubMed ID: 34552387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.
    Pomerantz JL; Denny EM; Baltimore D
    EMBO J; 2002 Oct; 21(19):5184-94. PubMed ID: 12356734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma.
    Dong G; Chanudet E; Zeng N; Appert A; Chen YW; Au WY; Hamoudi RA; Watkins AJ; Ye H; Liu H; Gao Z; Chuang SS; Srivastava G; Du MQ
    Clin Cancer Res; 2011 Mar; 17(6):1440-51. PubMed ID: 21266526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased circulating follicular regulatory T cells in Hashimoto's thyroiditis.
    Zhao J; Chen Y; Xu Z; Yang W; Zhu Z; Song Y; Liu J
    Autoimmunity; 2018 Nov; 51(7):345-351. PubMed ID: 30343599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.
    Arjunaraja S; Angelus P; Su HC; Snow AL
    Front Immunol; 2018; 9():198. PubMed ID: 29472930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.